NVDA

183.22

+0.84%↑

AVGO.US

349.52

-1.19%↓

ORCL

291.35

-6.81%↓

CSCO

70.15

+1.58%↑

CRM

243.13

-0.97%↓

NVDA

183.22

+0.84%↑

AVGO.US

349.52

-1.19%↓

ORCL

291.35

-6.81%↓

CSCO

70.15

+1.58%↑

CRM

243.13

-0.97%↓

NVDA

183.22

+0.84%↑

AVGO.US

349.52

-1.19%↓

ORCL

291.35

-6.81%↓

CSCO

70.15

+1.58%↑

CRM

243.13

-0.97%↓

NVDA

183.22

+0.84%↑

AVGO.US

349.52

-1.19%↓

ORCL

291.35

-6.81%↓

CSCO

70.15

+1.58%↑

CRM

243.13

-0.97%↓

NVDA

183.22

+0.84%↑

AVGO.US

349.52

-1.19%↓

ORCL

291.35

-6.81%↓

CSCO

70.15

+1.58%↑

CRM

243.13

-0.97%↓

Search

SS&C Technologies Holdings Inc

Suletud

SektorTehnoloogia

79.59 0.15

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

78.85

Max

80.15

Põhinäitajad

By Trading Economics

Sissetulek

-32M

181M

Müük

23M

1.5B

P/E

Sektori keskmine

25.568

76.006

Dividenditootlus

1.22

Kasumimarginaal

11.765

Töötajad

26,800

EBITDA

162M

520M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+23.75% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.22%

2.74%

Järgmine tulemuste avaldamine

23. okt 2025

Järgmine aktsia dividendi kuupäev (ex-date)

1. dets 2025

Turustatistika

By TradingEconomics

Turukapital

-731M

20B

Eelmine avamishind

79.44

Eelmine sulgemishind

79.59

Uudiste sentiment

By Acuity

50%

50%

166 / 408 Pingereas Technology

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

SS&C Technologies Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

17. okt 2025, 18:13 UTC

Suurimad hinnamuutused turgudel

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17. okt 2025, 17:05 UTC

Suurimad hinnamuutused turgudel

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

17. okt 2025, 15:03 UTC

Suurimad hinnamuutused turgudel

Obook Shares Sink Following Public Debut

17. okt 2025, 14:41 UTC

Suurimad hinnamuutused turgudel

Disc Medicine Shares Surge After FDA Grants Priority Voucher for EPP Drug

17. okt 2025, 23:25 UTC

Omandamised, ülevõtmised, äriostud

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17. okt 2025, 22:15 UTC

Market Talk

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17. okt 2025, 21:15 UTC

Market Talk

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17. okt 2025, 21:07 UTC

Market Talk

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17. okt 2025, 21:07 UTC

Market Talk

Global Equities Roundup: Market Talk

17. okt 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. okt 2025, 20:34 UTC

Market Talk

Deere Is Reaching the End of Its Downcycle -- Market Talk

17. okt 2025, 20:27 UTC

Market Talk

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17. okt 2025, 19:46 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17. okt 2025, 19:45 UTC

Market Talk

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17. okt 2025, 18:45 UTC

Market Talk

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17. okt 2025, 17:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. okt 2025, 17:51 UTC

Market Talk

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17. okt 2025, 17:44 UTC

Market Talk

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17. okt 2025, 17:35 UTC

Market Talk

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17. okt 2025, 16:20 UTC

Market Talk
Tulu

Tech, Media & Telecom Roundup: Market Talk

17. okt 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. okt 2025, 16:14 UTC

Market Talk

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17. okt 2025, 16:04 UTC

Market Talk

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17. okt 2025, 15:58 UTC

Market Talk

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17. okt 2025, 15:56 UTC

Tulu

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17. okt 2025, 15:43 UTC

Market Talk

Global Equities Roundup: Market Talk

17. okt 2025, 15:43 UTC

Market Talk

Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk

17. okt 2025, 14:58 UTC

Market Talk

Small-Business Trepidation in Canada Points to Economic Decline -- Market Talk

17. okt 2025, 14:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. okt 2025, 14:35 UTC

Market Talk
Tulu

American Express's Delayed Card Fee Hike Worries Some Investors -- Market Talk

Võrdlus sarnastega

Hinnamuutus

SS&C Technologies Holdings Inc Prognoos

Hinnasiht

By TipRanks

23.75% tõus

12 kuu keskmine prognoos

Keskmine 98.43 USD  23.75%

Kõrge 110 USD

Madal 88 USD

Põhineb 8 Wall Streeti analüütiku instrumendi SS&C Technologies Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

8 ratings

6

Osta

2

Hoia

0

Müü

Tehniline skoor

By Trading Central

75.15 / 78.1Toetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Strong Bullish Evidence

Sentiment

By Acuity

166 / 408 Pingereas Tehnoloogia

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest SS&C Technologies Holdings Inc

SS&C Technologies Holdings, Inc., together with its subsidiaries, provides software products and software-enabled services to financial services and healthcare industries. The company owns and operates technology stack across securities accounting; front-office functions, such as trading and modeling; middle-office functions comprising portfolio management and reporting; back-office functions, such as accounting, performance measurement, reconciliation, reporting, processing and clearing, and compliance and tax reporting; and healthcare solutions consisting of claims adjudication, benefit management, care management, and business intelligence solutions. Its products and services allow professionals in the financial services and healthcare industries to automate complex business processes and are instrumental in helping its clients to manage information processing requirements. The company's software-enabled services include SS&C GlobeOp, Global Investor and Distribution Solutions, SS&C Retirement Solutions, Black Diamond Wealth Platform, CRM Solutions, Advent Managed Services, Advent Data Solutions, ALPS Advisors, and Virtual Data Rooms, as well as pharmacy, healthcare administration, and health outcomes optimization solutions. Its software products comprise portfolio/investment accounting and analytics software, portfolio management software, trading software, automation solutions, and banking and lending solutions, as well as research, analytics, risk, and training solutions. The company also provides professional services that includes consulting and implementation services consisting of initial system installation, conversion of historical data, and ongoing training and support, as well as product support services. It operates in the United States; Europe, the Middle East, and Africa; the Asia Pacific and Japan; Canada; and the Americas. The company was founded in 1986 and is headquartered in Windsor, Connecticut.
help-icon Live chat